Complete metabolic response to combined BRAF/MEK inhibition (dabrafenib-trametinib) in BRAF V600E-mutated metastatic parotid adenocarcinoma: A case report

Oral Oncology Reports · Published 2026-08-02 · DOI 10.1016/j.oor.2026.100798

Free full text

Authors (4)

Andy Kouanga, Marie-Justine Paillard, Thierry Nguyen, Christophe Borg

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kouanga, A., Paillard, M., Nguyen, T., et al. (2026). Complete metabolic response to combined BRAF/MEK inhibition (dabrafenib-trametinib) in BRAF V600E-mutated metastatic parotid adenocarcinoma: A case report. Oral Oncology Reports. https://doi.org/10.1016/j.oor.2026.100798

Related articles

• HER3 and HPV in head and neck squamous cell carcinoma: Potential implications of induction chemotherapy on tumor immune microenvironment · Oral Oncology Reports · 2026 · Same journal
• Value of alpha smooth muscle actin (αSMA) and inducible nitric oxide synthase (iNOS) in oral squamous cell carcinoma (OSCC): An immunohistochemical approach to tumor stroma categorization and clinicopathological parameters · Oral Oncology Reports · 2025 · Same journal
• Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study · Oral Oncology Reports · 2025 · Same journal
• Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches · Oral Oncology Reports · 2025 · Same journal
• Utilization of ChatGPT as a reliable aide for differential diagnosis of histopathology in head and neck surgery · Oral Oncology Reports · 2025 · Same journal
• Compromised cervical lymphatic drainage following lymphadenectomy and radiation: an overview of head and neck lymphedema and its emerging pathophysiological implications · Oral Oncology Reports · 2026 · Same journal
• Oral care practices and oral mucositis in adult cancer patients receiving chemotherapy, or radiation therapy, or both in a private tertiary care hospital, Karachi, Pakistan · Oral Oncology Reports · 2026 · Same journal
• Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy · Oral Oncology Reports · 2025 · Same journal
• Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review · Oral Oncology Reports · 2025 · Same journal
• Transforming malignant salivary gland tumor (MSGTs) treatment with AlphaFold: A promising approach · Oral Oncology Reports · 2025 · Same journal